InsidersTradesSigma
Discover the full insider trade history of ALK-Abelló, a listed equity based in Denmark. Shares are quoted on DK DK, under the authority of Finanstilsynet DK. Operating in the Healthcare sector, ALK-Abelló has recorded 35 insider filings. Market capitalisation: €55.4bn. The latest transaction was filed on 21 March 2019 — Other. Among the most active insiders: Unknown. All data is free.
FY ended December 2025 · cache
0 of 0 declarations
ALK-Abelló is a company focused on developing treatments for allergies, particularly immunotherapies. It is listed on the XCSE exchange.